Autolus Therapeutics plc (AUTL)
SEC fundamentals · as filed in 10-Q FY2026, period ended Jun 30, 2026 · updated Oct 6, 2026
as filed in 10-Q FY2026, period ended Jun 30, 2026 · View filings on EDGAR ↗
In its 10-Q for the period ended Jun 30, 2026, Autolus Therapeutics plc reported revenue of $45.7M, net income of -$39.1M, and total assets of $493.2M. Every figure below is taken directly from Autolus Therapeutics plc's SEC filings: each links to the source document on EDGAR.
Revenue and net income by fiscal year
As reported in each year’s annual filing · USD
| Fiscal year | Revenue | Net income |
|---|---|---|
| FY2025 | $75.4M | -$287.5M |
| FY2024 | $10.1M | -$220.7M |
| FY2023 | $1.7M | -$208.4M |
| FY2022 | — | -$148.8M |
| FY2021 | — | -$142.1M |
Recent SEC filings
Filed by the registrant · newest first · insider forms and holder schedules not included
| Form | Filed | Source |
|---|---|---|
| 8-K | Aug 11, 2026 | on EDGAR ↗ |
| 10-Q | Aug 11, 2026 | on EDGAR ↗ |
| 8-K | Aug 3, 2026 | on EDGAR ↗ |
| 8-K | Aug 3, 2026 | on EDGAR ↗ |
| 8-K | Jun 29, 2026 | on EDGAR ↗ |
| 8-K | Jun 9, 2026 | on EDGAR ↗ |
| 10-Q | May 14, 2026 | on EDGAR ↗ |
| 8-K | May 14, 2026 | on EDGAR ↗ |
| 8-K | Apr 29, 2026 | on EDGAR ↗ |
| 8-K | Apr 16, 2026 | on EDGAR ↗ |
Balance Sheet
as of Jun 30, 2026 · 10-Q
Income Statement
10-Q (quarterly) · period ended Jun 30, 2026
| Revenue | $45.7M | Revenue | source ↗ |
| Net Income | -$39.1M | Net | source ↗ |
| Operating Income | -$43.8M | Operating | source ↗ |
| Gross Profit | $25.2M | Revenue−Cost | source ↗ |
| Cost of Revenue | $20.5M | Cost | source ↗ |
| R&D Expense | $27.9M | Research | source ↗ |
Per Share & Cash Flow
10-Q (quarterly) · period ended Jun 30, 2026
| EPS (diluted) | $-0.15 | Earnings | source ↗ |
| EPS (basic) | $-0.15 | Earnings | source ↗ |
| Shares Outstanding | 266.2M | Entity | source ↗ |
| Cash from Operations | -$25.1M | Net | source ↗ |
| Cash from Financing | -$2.1M | Net | source ↗ |
| Cash from Investing | $67.9M | Net | source ↗ |
Insider activity
Form 4 open-market activity, last 180 days
- Buys
- 0
- Sells
- 1
- Net shares
- -6.7K
Restatement history
Point-in-timeNo material restatements detected across 180 annual fact-keys: this company's as-filed numbers have held between filings. Point-in-time and as-of history are available via the API.
Deeper fundamentals
A free API key reaches AUTL’s revenue, margin and free-cash-flow trajectory (newest 3 fiscal years) and its leverage, liquidity and return ratios (newest 4 quarters). Analyst extends those to up to 20 years and 20 quarters, and adds the Piotroski F-score and accruals quality score. As-of fundamentals at any past date are on Free too, up to 10 lookups a day; Analyst removes that cap and adds the original-vs-restated detail, across the whole SEC universe.
Programmatic access
Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.
- These fundamentals, as filed
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/AUTL
MCP tool:
get_sec_fundamentals ticker=AUTL - The same figures as they were known on any past date
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/AUTL/as-of/YYYY-MM-DD
MCP tool:
get_asof_fundamentals ticker=AUTL as_of=YYYY-MM-DD - Fiscal-year trajectory: revenue, margins, free cash flow
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/AUTL/history
MCP tool:
get_fundamentals_history ticker=AUTL - Leverage, liquidity, margin and return ratios
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/financial-health/AUTL
MCP tool:
get_financial_health ticker=AUTL
Not investment advice. Figures are shown as filed with the SEC; see the EDGAR source links for the original documents. Data may lag the latest filing.